Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer
Clinical trial NCT04982939 · UNKNOWN
Trial details
- NCT number
- NCT04982939
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-21
- Primary completion
- 2023-06-21
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.